SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-22-024692
Filing Date
2022-10-25
Accepted
2022-10-25 16:16:10
Documents
19

Document Format Files

Seq Description Document Type Size
1 FORM S-1 nby20221024_s1.htm   iXBRL S-1 541132
2 EXHIBIT 5.1 ex_436297.htm EX-5.1 17104
3 EXHIBIT 23.1 ex_436298.htm EX-23.1 2932
4 EXHIBIT 23.2 ex_436299.htm EX-23.2 3122
5 EXHIBIT FILING FEES ex_436300.htm EX-FILING FEES 14958
10 nb01.jpg GRAPHIC 7380
11 squire01.jpg GRAPHIC 4452
  Complete submission text file 0001437749-22-024692.txt   792015

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20221025.xsd EX-101.SCH 3594
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20221025_def.xml EX-101.DEF 8911
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20221025_lab.xml EX-101.LAB 11767
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20221025_pre.xml EX-101.PRE 8682
13 EXTRACTED XBRL INSTANCE DOCUMENT nby20221024_s1_htm.xml XML 2069
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-268002 | Film No.: 221329672
SIC: 2834 Pharmaceutical Preparations